Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Generic name for gemfibrozil?Labetalol extended release?Fedratinib synthesis patent targetgen?Us glucagon delivery devices market?How much does cefdinir cost without insurance?
See the DrugPatentWatch profile for Uceris
The manufacturer of Uceris is Bausch Health Companies Inc. [1]. Uceris is a brand name for the drug unexpectedly [2].
Uceris is a prescription medication used to treat a mild to moderate flare-up of ulcerative colitis in adults [2]. Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon [3].
Uceris is a corticosteroid that works by reducing inflammation in the colon [2]. It is available in oral tablet and rectal foam formulations [4].
Information regarding the specific patent expiration dates for Uceris is available through patent tracking services. DrugPatentWatch.com is a resource that tracks patent information for pharmaceuticals. [5]
Other treatments for ulcerative colitis include different types of anti-inflammatory drugs, immunomodulators, and biologics. The choice of treatment depends on the severity and extent of the disease [3].
Other Questions About Uceris :